Alpine Immune Sciences Overview

Alpine Immune Sciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ALPN.

Quarterly EBIT

-$22.70M

↓ 45.56% YoY

As of Mar 31, 2024

Annual EBIT (TTM)

-$46.00M

↑ 30.6% YoY

Trailing 12 months ending Mar 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin